HIGHLIGHTS
- who: Matteo Ferro and colleagues from the (UNIVERSITY) have published the research: Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer, in the Journal: Diagnostics 2022, 12, 1981. of 16/08/2022
SUMMARY
Despite the improvements in available therapies and technologies, up to 27-53% of patients report a biochemical failure, i.e., a prostate specific antigen (PSA) level of >0.4 ng/mL or any PSA increase of >2 ng/mL higher than the PSA nadir value. If the treatment of metastatic prostate cancer is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.